|
Sztein, M B; Tanner, M K; Polotsky, Y et al. (1995) Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J Immunol 155:3987-93
|
|
Wasserman, S S; Losonsky, G A; Noriega, F et al. (1994) Kinetics of the vibriocidal antibody response to live oral cholera vaccines. Vaccine 12:1000-3
|
|
Wasserman, S S; Kotloff, K L; Losonsky, G A et al. (1993) Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect. Am J Epidemiol 138:988-93
|
|
Murphy, J R (1993) Diarrhoeal disease: current concepts and future challenges. Rapid detection of enteric infections by measurement of enteric pathogen-specific antibody secreting cells in peripheral blood. Trans R Soc Trop Med Hyg 87 Suppl 3:27-30
|
|
Hone, D M; Tacket, C O; Harris, A M et al. (1992) Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest 90:412-20
|
|
Suharyono; Simanjuntak, C; Witham, N et al. (1992) Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 340:689-94
|
|
Keay, S; Tacket, C O; Murphy, J R et al. (1992) Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1. AIDS Res Hum Retroviruses 8:1091-8
|
|
Herrington, D A; Losonsky, G A; Smith, G et al. (1992) Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine 10:841-6
|
|
Dolin, R; Graham, B S; Greenberg, S B et al. (1991) The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med 114:119-27
|
|
Murphy, J R; Grez, L; Schlesinger, L et al. (1991) Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun 59:4291-3
|
Showing the most recent 10 out of 25 publications
